Top Japanese Biotech Companies Exhibit at Bio Convention in San Diego
June 5, 2014 (Source: Marketwired) — The Japan External Trade Organization (JETRO) is coordinating the Japan Pavilion at the 2014 BIO International Convention (BIO 2014), to be held at the San Diego Convention Center Tuesday, June 24 through Thursday, June 26. Nineteen Japanese companies will participate in the Pavilion (Booth 525), representing some of Japan’s most innovative biotechnology.
Key technologies to be exhibited at BIO 2014 include new treatments for oncology, pain management, cognitive and neurological disorders; advancements in regenerative medicine; drug discovery tools; and contract manufacturing and R&D. Three companies in the Japan Pavilion will be representing technologies developed at some of Japan’s leading universities. In addition, three organizations are exhibiting at the BIO Convention for the first time:
- World Fusion, which provides tools for drug discovery, genomics research and data mining.
- Molcure, which manufactures antibody drugs using automated robotic technology.
- Medical & Biological Laboratories, which develops reagents for clinical & research applications, including specialized reagents for genetic research.
Get our daily investorintel update
The delegates will also participate in BIO’s One-on-One Partnering meetings. The Japanese exhibitors are eager to meet new strategic development and distribution partners. Detailed company profiles are online at www.jetro.go.jp/usa/pdf/BIO2014.pdf
Japan is the world’s second-largest life science market, accounting for approximately 10% of global drug and medical device sales. In 2012, revenues for the Japanese biotechnology market totaled more than $43.3 Billion; by 2017, the market is expected to grow to $53.8 Billion.
The annual BIO Convention, organized by the Biotechnology Industry Organization, is the largest event for the biotechnology sector, attracting over 16,000 attendees from all over the world. JETRO has organized the Japan Pavilion at the BIO Convention since 2003.
As the Japanese government’s economic development agency, JETRO promotes trade and investment between Japan and the rest of the world. Utilizing our network of more than 70 overseas offices and 40 in Japan, JETRO carries out a range of activities, including: facilitating foreign direct investment into Japan; helping Japanese firms maximize their export potential; and promoting Japanese products abroad.
In the life science sector, JETRO provides market information and consulting to Japanese companies interested in entering foreign markets and to foreign companies interested in expanding into Japan. JETRO also coordinates periodic business matching opportunities at conferences and tradeshows around the world.
InvestorIntel is a trusted source of reliable information at the forefront of emerging markets that brings investment opportunities to discerning investors.